Promoter holding
64.27%
MP
Medi Plus (India) Limited - Due diligence report
A 360° intelligence report on Mediplus India: trust score, financial health, credit view, compliance, directors, growth and distress signals…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Mediplus India — 360° Intelligence Report
Generated from MCA filings & public records88/100
Trust Score
Low Risk
Mediplus India is assessed as Low Risk with a Trust Score of 88/100. Mediplus India is an active public limited indian non-government company incorporated in 1994, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.
Report generated on 17 Jul 2026 from the latest processed filings. Medi Plus (India) Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
88/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
73/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Open charges exceed net worth - secured lenders rank ahead.
- Moderate gearing (D/E 1.42).
- Profitable - internal accruals available.
- Externally credit-rated (BBB).
Charges position: 3 open (49.89 cr) · 9 satisfied (65.12 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| State Bank Of India | 6 | 48.0 cr |
| Axis Bank Limited | 2 | 48.0 cr |
| Hdfc Bank Limited | 3 | 48.0 cr |
| Others | 1 | 48.0 cr |
Compliance Score: 73/100 Moderate
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- Litigation present in 1 court forum(s).
- Delayed payments to MSME suppliers disclosed (41 disclosure(s)).
- 2 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ALKA GOEL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUNDER LAL GOEL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| LEELA WATI GOEL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NAVNEET JERATH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAGHAV GOEL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| CHIRAG | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANDEEP GOEL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 7 directors on the board.
- No disqualified or deactivated DINs.
- 2 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Key managerial personnel: ALKA GOEL (Whole-time director) · SUNDER LAL GOEL (Whole-time director) · LEELA WATI GOEL (Whole-time director) · SANDEEP GOEL (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
Net margin improved to 38%.
Operating for 31+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
3 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 92.19 Lakh.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence83/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment85/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 3 open charge(s) of 49.89 cr already registered.
- Compliance record supports lending.
Investor view93/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 5 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events29 Sep 2025
Director ceased
NAVNEET JERATH
Director ceased
CHIRAG
06 Jun 2025
Director appointed
NAVNEET JERATH (Director)
Director appointed
CHIRAG (Director)
07 Apr 2025
Charge satisfied
Hdfc Bank Limited
26 Dec 2024
Charge created
Hdfc Bank Limited - 60.00 Lakh
14 Nov 2024
Charge satisfied
Hdfc Bank Limited
02 Nov 2024
Charge satisfied
Axis Bank Limited
30 Sep 2024
Last AGM held
Annual general meeting
18 Jul 2024
Charge created
Others - 30.00 Lakh
31 Mar 2024
Latest balance sheet
Filed with ROC
27 Jul 2023
Charge satisfied
State Bank Of India
25 Mar 2022
Charge created
Hdfc Bank Limited - 8.00 Lakh
19 Nov 2021
Charge created
Hdfc Bank Limited - 14.98 Lakh
10 Nov 2021
Charge created
Axis Bank Limited - 78.81 Lakh
10
Key Observations
Auto-generated from the data aboveRevenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
7 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of BBB from Care.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
| Company | CIN | Location |
|---|---|---|
| Janak Healthcare | U36100MH1999PTC122868 | Mumbai, Maharashtra, India |
| Shija Hospitals & Research Institute | U85101MN1998PTC005626 | Imphal West, Manipur, India |
| Venor Pharma Limited | U74900DL2013PLC251565 | Delhi, Delhi, India |
| Crystal Medicines Private Limited | U24230MH2004PTC148426 | Mumbai, Maharashtra, India |
| Mdd Medical Systems (India) Private Limited | U33119DL2003PTC123016 | Delhi, Delhi, India |
| Fortis | U85110DL2003PLC120016 | Delhi, Delhi, India |
| 108 Emergency Medical Transport Services West (Up) | U85100TG2019NPL131388 | Secunderabad, Telangana, India |
| Sunshine Global Hospitals | U85110GJ2007PTC051728 | Baroda, Gujarat, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Mediplus India before audits and certifications: compliance score 73/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Mediplus India: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Mediplus India - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Mediplus India pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Mediplus India - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Mediplus India an active company?
Mediplus India has MCA status “Active” with a compliance score of 73/100 (Moderate).
Is Mediplus India financially healthy?
Mediplus India has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Mediplus India?
Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Mediplus India?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 7 active director(s) are on record.
Does Mediplus India have loans or charges against its assets?
3 open charge(s) are registered against its assets, and 9 earlier charge(s) stand satisfied.
Is Mediplus India up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 73/100 (Moderate).
Is it risky to lend to Mediplus India?
Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
